Alkermes plc Reports First Quarter 2022 Financial Results

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2022. "Our strong first quarter results reflect continued...

Related Keywords

Athlone ,Westmeath ,Ireland ,Waltham ,Massachusetts ,United States ,Ohio ,Dublin ,American ,Katie Joyce ,Iain Brown ,Sandy Coombs ,Alkermes ,American Society Of Clinical Oncology ,Schizophrenia International Research Society ,Drug Administration ,Baudax Bio Inc ,Johnson Corporation ,Biogen Inc ,Nasdaq ,Exchange Commission ,Alkermes Inc ,Alkermes Pharma Ireland ,Society Of Gynecologic Oncology ,First Quarter Revenues ,Reflect Strong Performance ,Financial Expectations ,Richard Pops ,Chief Executive Officer ,Ended March ,Goods Manufactured ,Baudax Bio ,Chief Financial Officer ,American Society ,Clinical Oncology ,Gynecologic Oncology ,Private Securities Litigation Reform Act ,Annual Report ,Alkermes Pharma Ireland Limited ,Viiv Healthcare United Kingdom ,Financial Information ,Consolidated Statements ,Months Ended ,Earnings Per Share ,Average Number ,Ordinary Shares Outstanding ,Quarterly Report ,